Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

CRLCC Francois Baclesse, Oncologie medicale, Caen

Center for Cancers and Blood Disorders, Bethesda

ASKLEPIOS Klinik Altona, Hamburg

Virginia Cancer Institute, Richmond

Ostholstein-Onkologie, Oldenburg in Holstein

South Carolina Oncology Associates, Columbia

Northwest Georgia Oncology Centers, Marietta

Florida Cancer Specialists, Fort Myers

Centre Eugène Marquis, Rennes

Tennessee Oncology Sarah Cannon Research, Nashville

Chattanooga Oncology & Hematology Associates, PC, Chattanooga

Institut de Cancerologie de la Loire, Saint-Priest-en-Jarez

Kliniken Essen-Mitte, Essen

Oncology Hematology Care Inc., Cincinnati

Centre Oscar Lambert, Lille

Research Medical Center, Kansas City

Centre Léon Bérard, Oncologie, Lyon

Baton Rouge Medical Center, Baton Rouge

Centre Henri Becquerel, Oncologie Médicale, Rouen

South Texas Oncology and Hematology, San Antonio

Institut Gustave Roussy IGR, Villejuif

H:S Rigshospital, The Finsen Centre, Copenhagen

Carl-Gustav-Carus Medicinische Klinik und Poliklinik I, Dresden